Neuroprotective Effects of Shiliuwei Kangchanzhijing Capsules in Rotenone-Induced Parkinson's Disease Mouse Model: Involvement of the Parkin/PP2A/α-Syn Pathway.

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopaminergic neurons in the substantia nigra and the pathological accumulation of α-synuclein (α-Syn). Rotenone, a mitochondrial complex I inhibitor, reliably…

Preview only. Read the full abstract at the source